Transaction details
Jean F Holloway, serving as senior vice president and general counsel at Artivion Inc. (NASDAQ: AORT), sold 2,183 shares of common stock on March 2, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares were disposed of at a price of $38.0249 per share, producing gross proceeds of $83,008. The filing specifies that the sale was executed to satisfy tax withholding obligations associated with the vesting of restricted stock units and was not a discretionary transaction.
Post-transaction ownership and market context
After the sale, Holloway is reported to directly hold 170,105 shares of Artivion. At the time surrounding the disclosed transaction, AORT shares were trading at $38.62, a price level that represents an approximate 54% increase over the preceding 12 months.
Valuation and company metrics
Investment research referenced in the filing indicates that, per InvestingPro analysis, Artivion appears overvalued relative to Fair Value estimates. The company is noted to be profitable and carries a market capitalization of $1.85 billion. The filing also points readers toward further proprietary analysis and additional ProTips available in a dedicated Pro Research Report for subscribers seeking deeper context.
Recent operating results
Artivion reported fourth-quarter results for 2025 that outpaced earnings expectations, recording earnings per share of $0.17 versus a forecast of $0.06. On the top line, adjusted fourth-quarter revenues amounted to $118.3 million, described as an 18.5% year-over-year increase on a constant currency basis and excluding a one-time $2.3 million payment to the Italian government. That adjusted revenue figure topped Canaccord Genuity’s estimate of $115.6 million and the consensus expectation of $116.5 million.
Despite slightly missing revenue forecasts, the company's performance was characterized by strength in key product areas and progress on strategic growth initiatives.
Analyst action
Canaccord Genuity retained a Buy rating on Artivion but reduced its price target to $48.00 from $51.00, citing compressed multiples among comparable groups in the wake of a recent market sell-off. The firm’s maintained rating alongside a lower target reflects both endorsement of the business momentum and caution tied to broader valuation pressures.
For investors and market participants, the Form 4 filing provides a clear administrative rationale for the insider sale while the company’s quarterly results and the analyst reaction together outline current opportunities and valuation tensions facing Artivion.